The CoGenesis® platform is transforming healthcare through advanced genetic testing and bioinformatics solutions. Our comprehensive services empower healthcare professionals in making informed medical decisions, from diagnostics and disease monitoring to treatment response.
CoGenesis® Neuro detects 505 genes associated with neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS), Spinocerebellar Ataxia (SCA), Wilson Disease, and more. In collaboration with Prince of Wales Hospital, CoGenesis® has helped over 120 undiagnosed neuro disorder patients identify their genetic profiles, reducing diagnostic times from 10 years to just 1 month.
We also offer genetic testing for oncology, cardiology, ophthalmology, and developmental diseases with various sizes of gene coverage. Partnering with international brands like Guardant Health, we provide comprehensive genetic solutions for cancer patients throughout their journey, from early screening and disease monitoring to diagnosis and treatment options.
